484
NGHIÊN CU MT S M CA SUY TIM MN TÍNH TI KHOA NI
TIM MCH BNH VIK LK T THÁNG 10/2010 04/2011
Nguyn Th
Khoa Tim mch, Bnh vik Lk
.
k Lk
- 04/2011.
SUMMARY
STUDY OF SOME FEATURES CHRONIC HEART FAILURE
IN DEPARTMENT CARDIOVASCULAR INTERNAL - DAK LAK GENERAL HOSPITAL
FROM 10/2010 - 04/2011
Introduction: Chronic heart failure is the ultimate consequence of cardiovascular disease,
but this disease can be prevented, and if diagnosed, early treatment will increase your chances of
living, improved quality of life for patients, reducing the cost of treatment.
Objectives: Clinical features, and clinical stage of heart failure in patients with chronic heart
failure is treated. Identify some characteristics of the causes of chronic heart failure are common.
Subjects and methods: cross-sectional study described in all patients diagnosed with chronic
heart failure treatment in Department cardiovascular internal - Dak Lak general hospital in the
study period from 10/2010 - 04/2011.
Results: The incidence of chronic heart failure increases with age. The common clinical
symptoms of chronic heart failure are prominent, breathing difficulties which occur in 100% of
cases, fatigue is 93.10%. Most patients had grade III heart failure, according to NYHA
percentage of 59.48% and 43.96% under the Vietnam Association of Internal Medicine. 69.97%
of patients in the study group is looking to shadow images's large heart, 70% of our patients with
the phenomenon of expansion chambers of the heart, EF falls below 40% share of 10.04%,
76.72% of patients have increased pulmonary artery pressure. Topping causes of chronic heart
failure is heart valve disease accounted for 37.37% rate, followed by hypertension accounted for
22.42% rate, the rate of coronary heart disease accounted for 17.24%, disorders heart rate
percentage 13.79% and 9.48% is due to other causes. Although the cause of chronic heart failure
but can vary, but you have chronic heart failure, symptoms of the common clinical
manifestations were almost equally dominant. Patients with chronic heart failure due to coronary
artery disease and hypertension is often preserved EF.
485
7, theo nghiên
-
, trong
13- 2%
15.
-
9.
ính, song
7.
h -
II.
- - 04/2011.
1113
Tim to
Phù chi
Gan to
Dun
Tim nhanh > 120 l/ph
486
-
-
-
-
-
-
Nam
n
%
n
%
< 30
0
0,00
2
1,73
5
4,31
4
3,45
9
7,76
5
4,31
16
13,79
10
8,62
19
16,38
11
9,48
> 70
20
17,24
15
12,93
69
59,48
47
40,52
n
%
Khó th
116
100
57
49,14
108
93,10
52
44,83
42
36,21
Phù
72
62,09
Gan to
93
80,17
91
78,45
53
45,69
61
52,59
cao 93,1%.
1
2
3
4
n
%
n
%
n
%
n
%
18
15,52
28
24,14
41
35,34
29
25,00
2,70 ± 1,01
Gan
23
19,83
53
45,69
28
24,14
12
10,34
2,25 ± 0,89
Phù
44
37,93
45
38,79
19
16,38
8
6,90
1,91 ± 0,90
55
47,41
48
41,38
11
9,48
2
1,73
1,66 ± 0,72
487
- Khó t
-
I
II
III
IV
n
%
n
%
n
%
n
%
NYHA
0
0,00
18
15,52
69
59,48
29
25,00
18
15,52
28
24,14
51
43,96
19
16,38
n
%
X Quang
ngc thng
Bóng tim to
80
69,97
63
54,31
ECG
70
60,34
31
26,72
62
53,45
Siêu âm
Doppler tim
82
70,69
65
56,03
89
76,72
tim trong siêu âm.
n
%
Min
Max
Trung
bình
EF (%)
>55
ng
51
43,97
21
81
56,25 ±
14,16
50
26
22,41
40
27
23,28
12
10,34
(mmHg)
<30
36
31,04
22
101
47,60 ±
20,71
55
47,41
>60
25
21,55
- t là 21%.
-
Nguyên nhân
n
%
BLVT
43
37,07
THA
26
22,42
BMV
20
17,24
RLNT
16
13,79
NNK
11
9,48
116
100
488
hân suy tim
IV.
59
13.
13
Nguyên nhân
< 30
50
>70
n
%
n
%
n
%
n
%
n
%
n
%
BLVT
1
2,33
4
9,30
7
16,28
11
25,58
13
30,23
7
16,28
43
THA
0
0
2
7,69
2
7,69
7
26,92
6
23,08
9
34,62
26
BMV
0
0
2
10,00
3
15,00
4
20,00
6
30,00
5
25,00
20
RLNT
0
0
0
0
2
12,50
2
12,50
3
18,75
9
56,25
16
NNK
1
9,09
1
9,09
0
0
2
18,18
2
18,18
5
45,46
11
2
9
14
26
30
35
116
Nguyên nhân
Nam
n
%
n
%
Bnh lý van tim
16
37,21
27
62,79
43
17
65,38
9
34,62
26
12
60,00
8
40,00
20
14
87,50
2
12,50
16
Nguyên nhân khác
10
90,91
1
09,09
11
69
47
116
489
nh Kim Gàn, Nguyn Phú
Quí, Phm Ngc 2.
-
10], [11]. Theo
khác [9 ProBNP cho phép ta
71011
Theo NY
- Trên X Quang:
suy tim là 62% , 67%, 32% [15].
5.
- Siêu âm doppler tim:
[15], [17]
915.
490
-
13.
1.
15.
-
50
-
-
-
-
-
5.2. Nguyên nhân suy tim
-
491
- Cho dù nguyên nhân gây ra suy tim
-
-
-
tính.
1.
1999: 6 11.
2. Hunh Kim Gàn, Nguyn Phú Quí, Phm Ngc ng và CS (2008), NT-
ProBNP bnh nhân suy tim mn tính, Hà Ni 2008.
3. Minh (2006), Suy tim,
30.
4. - Khoa Y
- 65.
5. ), Suy tim,
2007: 393 427.
6. Hà
63.
7.
.
8. V ình Hi, Nguyn Th Trúc, Tr Trinh, Phm Nguyn Vinh (1998), suy
tim, K yu toàn v tài khoa hi hi Tim mch hc Quc gia ln th VII ,
t 1998: 26 - 32.
9. American Heart Association (2009), Heart disease and Stroke statistics, Journal of The
American Heart Association: 81 82.
10. Barbara G.Wells, Joseph T.Dipiro, Terry L.Schwinghammer, Cecily V.Dipiro (2009), Heart
Failure, Pharmacotherapy handbook ,The McGraw-Hill Companies, Inc, USA: 82 97.
11. Eugene Braunwald (2005), Heart Failure and Cor Pulmonale,
Internal Medicine, The McGraw-Hill Companies, Inc, USA: 1367 1378.
12. John D.Bisognano, Mark L.Baker, Mary Beth Earley (2009), Systolic Heart Failure,
Manual of Heart Failure Management, Department of Medicine, Cardiology Division,
University of Rochester, Rochester, NY, USA: 49 57.
13. Kalon K. L.Ho, Joan L.Pinsky, William B.Kannel, Daniel Levy (1993), The
Epidemiology of Heart Failure, The Framingham Study, J Am Coll Cardiol: 6A 13A.
14. Mario J. GARCIA, Diastolic heart failure, A clinical quandary, Patient Care 200: 13-24.
15. M. R. Cowie, A. Mosterdft, D. A. Wood, J. W. Deckers, P. A. Poole-Wilson, G. C. Sutton and
D. E. Grobbeef (1997), The epidemiology of heart failure, European Heart Journal: 208-225.
16. Marjorie Funk, Kerry A.Milner, Harlan M.Krumholz (2001), Epidemiology of Heart
Failure, Improving Outcomes in Heart Failure, Aspen Publishers, Inc, USA: 3 15.
17. Specific Disease - Related Problems in
Diastolic Heart Failure, Diastolic Heart Failure, Springer Verlag London: 243 - 271
18. Russell J Greene, Norman D Harris (2007), Heart Failure, Pathology and Therapeutics for
Pharmacists, 186 208.
492